# Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients

> **NCT04691765** · PHASE1 · UNKNOWN · sponsor: **Dr. David Spaner** · enrollment: 12 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Kineret

## Key facts

- **NCT ID:** NCT04691765
- **Lead sponsor:** Dr. David Spaner
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2021-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04691765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04691765, "Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04691765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*